These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1415 related items for PubMed ID: 19149498

  • 1. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
    Babizhayev MA, Kasus-Jacobi A.
    Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
    [Abstract] [Full Text] [Related]

  • 2. N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients.
    Babizhayev MA, Micans P, Guiotto A, Kasus-Jacobi A.
    Am J Ther; 2009 Jan; 16(6):517-33. PubMed ID: 19487926
    [Abstract] [Full Text] [Related]

  • 3. N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications.
    Babizhayev MA, Guiotto A, Kasus-Jacobi A.
    J Drug Target; 2009 Jan; 17(1):36-63. PubMed ID: 19037813
    [Abstract] [Full Text] [Related]

  • 4. N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population.
    Babizhayev MA, Burke L, Micans P, Richer SP.
    Clin Interv Aging; 2009 Jan; 4():31-50. PubMed ID: 19503764
    [Abstract] [Full Text] [Related]

  • 5. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA.
    Drugs R D; 2005 Jan; 6(6):345-69. PubMed ID: 16274259
    [Abstract] [Full Text] [Related]

  • 6. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
    Babizhayev MA.
    Drug Test Anal; 2012 Jun; 4(6):468-85. PubMed ID: 21416634
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of intraocular absorption and drug metabolism of N-acetylcarnosine lubricant eye drops: drug interaction with sight threatening lipid peroxides in the treatment for age-related eye diseases.
    Babizhayev MA.
    Drug Metabol Drug Interact; 2009 Jun; 24(2-4):275-323. PubMed ID: 20408504
    [Abstract] [Full Text] [Related]

  • 8. Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique.
    Babizhayev MA, Yegorov YE.
    Recent Pat Drug Deliv Formul; 2016 Jun; 10(2):82-129. PubMed ID: 26084629
    [Abstract] [Full Text] [Related]

  • 9. Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes.
    Babizhayev MA, Deyev AI, Yermakova VN, Brikman IV, Bours J.
    Drugs R D; 2004 Jun; 5(3):125-39. PubMed ID: 15139774
    [Abstract] [Full Text] [Related]

  • 10. Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery.
    Babizhayev MA.
    Drug Dev Ind Pharm; 2008 Oct; 34(10):1071-89. PubMed ID: 18777243
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel intraocular and systemic absorption drug delivery and efficacy of N-acetylcarnosine lubricant eye drops or carcinine biologics in pharmaceutical usage and therapeutic vision care.
    Babizhayev MA, Khoroshilova-Maslova IP, Kasus-Jacobi A.
    Fundam Clin Pharmacol; 2012 Oct; 26(5):644-78. PubMed ID: 21793899
    [Abstract] [Full Text] [Related]

  • 13. Biomarkers of oxidative stress and cataract. Novel drug delivery therapeutic strategies targeting telomere reduction and the expression of telomerase activity in the lens epithelial cells with N-acetylcarnosine lubricant eye drops: anti-cataract which helps to prevent and treat cataracts in the eyes of dogs and other animals.
    Babizhayev MA, Yegorov YE.
    Curr Drug Deliv; 2014 Oct; 11(1):24-61. PubMed ID: 24783234
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The natural histidine-containing dipeptide Nalpha-acetylcarnosine as an antioxidant for ophthalmic use.
    Babizhayev MA, Yermakova VN, Semiletov YA, Deyev AI.
    Biochemistry (Mosc); 2000 May; 65(5):588-98. PubMed ID: 10851037
    [Abstract] [Full Text] [Related]

  • 16. Current ocular drug delivery challenges for N-acetylcarnosine: novel patented routes and modes of delivery, design for enhancement of therapeutic activity and drug delivery relationships.
    Babizhayev MA.
    Recent Pat Drug Deliv Formul; 2009 Nov; 3(3):229-65. PubMed ID: 19534670
    [Abstract] [Full Text] [Related]

  • 17. Biological activities of the natural imidazole-containing peptidomimetics n-acetylcarnosine, carcinine and L-carnosine in ophthalmic and skin care products.
    Babizhayev MA.
    Life Sci; 2006 Apr 11; 78(20):2343-57. PubMed ID: 16388826
    [Abstract] [Full Text] [Related]

  • 18. Structural and functional properties, chaperone activity and posttranslational modifications of alpha-crystallin and its related subunits in the crystalline lens: N-acetylcarnosine, carnosine and carcinine act as alpha- crystallin/small heat shock protein enhancers in prevention and dissolution of cataract in ocular drug delivery formulations of novel therapeutic agents.
    Babizhayev MA.
    Recent Pat Drug Deliv Formul; 2012 Aug 11; 6(2):107-48. PubMed ID: 22436026
    [Abstract] [Full Text] [Related]

  • 19. Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-angle glaucoma.
    Babizhayev MA.
    BBA Clin; 2016 Dec 11; 6():49-68. PubMed ID: 27413694
    [Abstract] [Full Text] [Related]

  • 20. New concept in nutrition for the maintenance of the aging eye redox regulation and therapeutic treatment of cataract disease; synergism of natural antioxidant imidazole-containing amino acid-based compounds, chaperone, and glutathione boosting agents: a systemic perspective on aging and longevity emerged from studies in humans.
    Babizhayev MA.
    Am J Ther; 2010 Dec 11; 17(4):373-89. PubMed ID: 20463577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.